Please find enclosed the Annual Secretarial Compliance Report issued by Mr. Vishal Manseta, Company Secretary in Practice, for the financial year ended 31/March/2026.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Sudarshan Pharma Industries Ltd has submitted its Annual Secretarial Compliance Report for the financial year ended March 31, 2026, as required under SEBI Regulation 24A. The report, certified by Practicing Company Secretary Vishal N. Manseta, confirms that the company has complied with all applicable SEBI regulations including LODR, ICDR, SAST, PIT, and Depositories regulations. No violations or deviations were found during the review period. The report notes the company had previously responded to a BSE query in February 2024 regarding financial parameters, providing full cooperation. Additionally, the company issued Foreign Currency Convertible Bonds of USD 20 million after the end of the review period.
A clean compliance report with no deviations or penalties is a positive signal for investors, indicating strong corporate governance and regulatory adherence. The absence of any disqualification of directors or SEBI actions reinforces the company's regulatory standing.